How should pleurodiaphragmatic adhesion be diagnosed and managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis and Management of Pleurodiaphragmatic Adhesion

Diagnostic Approach

Pleurodiaphragmatic adhesions should be diagnosed using respiratory dynamic CT (RD-CT) or four-dimensional CT during natural breathing, which provides superior preoperative detection compared to standard imaging, with specificity reaching 86.8% when the CT-Respiration Ratio is less than 0.65. 1, 2

Imaging Modalities

  • Respiratory dynamic CT (RD-CT) should be performed with inspiration and expiration phases to assess synchronous motion during respiration, as sliding score correlates inversely with adhesion severity 1
  • For patients who cannot maintain constant respiratory rhythm (elderly, those with respiratory dysfunction), four-dimensional CT during natural breathing is equally effective, measuring migration distance between the lesion and chest wall (mean 0.8 ± 0.2 cm with adhesions vs 2.6 ± 1.8 cm without) 2
  • Transthoracic ultrasonography outperforms standard CT for detecting septations, with 81-88% sensitivity and 83-96% specificity, and should be used when loculated collections are suspected 3
  • Standard chest radiographs may show ill-defined or tented diaphragmatic outlines, though this can represent normal anatomical variation of the pulmonary ligament rather than pathological adhesions 4

Clinical Context Assessment

  • Obtain detailed asbestos exposure history, as diffuse pleural thickening with adhesions occurs in 9-22% of asbestos-exposed workers and increases with time from first exposure 3
  • Assess for prior pleural inflammation or effusion, as adhesions commonly develop following acute pleuritis, repeated thoracentesis, or previous pleurodesis attempts 3
  • Evaluate dyspnea severity in relation to the extent of pleural involvement, as adhesions causing restrictive impairment may reduce FVC by 270 ml regardless of radiographic extent 3

Management Strategy

Conservative Management

For asymptomatic or minimally symptomatic pleurodiaphragmatic adhesions discovered incidentally, observation with serial pulmonary function testing is appropriate, monitoring for progressive restrictive impairment. 3

  • Perform baseline spirometry to document FVC and establish restrictive pattern (characteristic preservation of diffusing capacity with reduced lung volumes) 3
  • Schedule follow-up pulmonary function tests every 6-12 months to detect progression, as diffuse pleural thickening can cause FVC decrements two-fold greater than circumscribed plaques 3
  • Monitor for development of pachypleuritis (extensive bilateral fibrosis with active inflammation), which may progress to ventilatory failure and require surgical intervention 3

Surgical Intervention

When adhesions cause significant symptoms or complicate planned thoracic procedures, thoracoscopic adhesiolysis is preferred over open thoracotomy, though extensive adhesions may necessitate conversion. 3

Preoperative Planning

  • Use RD-CT or 4D-CT findings to determine surgical approach, as sensitivity reaches 77.8% in patients with CT-Respiration Ratio <0.65 1
  • Recognize that extensive dorsal pleural adhesions, involvement of ≥2 areas including dorsal pleura, or extensive mediastinal adhesions predict prolonged air leak (odds ratio 2.83) and should prompt patient counseling about extended hospitalization 5
  • Prepare for conversion to open thoracotomy when preoperative imaging suggests dense adhesions preventing safe thoracoscopic visualization 3

Surgical Technique

  • Medical thoracoscopy allows direct visualization and biopsy of visceral and diaphragmatic pleura under local anesthesia with conscious sedation, reducing diagnostic uncertainty to <10% 3
  • VATS requires general anesthesia and single-lung ventilation but enables more extensive adhesiolysis using multiple ports 3
  • When adhesions prevent safe VATS insertion or adequate visualization, convert to open thoracotomy rather than risk complications from inadequate exposure 3
  • Use bipolar electrocautery or ultrasonic devices instead of monopolar cautery to minimize thermal injury and reduce risk of further adhesion formation 3

Adhesion Prevention Strategies

  • Apply hyaluronate carboxymethylcellulose (Seprafilm®) barriers, which decrease reoperation for adhesive complications by 51% (RR 0.49; 95% CI 0.28-0.88) 6
  • Consider icodextrin (Adept®) liquid barrier for laparoscopic approaches, reducing recurrent adhesive complications (RR 0.20; 95% CI 0.04-0.88) 6
  • Avoid starch-powdered gloves and minimize foreign body reactions that aggravate adhesion formation 3

Management of Trapped Lung

When adhesions cause trapped lung (inability to achieve complete lung expansion), pleurodesis is contraindicated and indwelling pleural catheter placement should be considered instead. 3

  • Suspect trapped lung when initial pleural fluid pressure is <10 cm H₂O at thoracentesis or when pressure exceeds 19 cm H₂O after removing 500 ml of fluid 3, 7
  • Confirm with bronchoscopy to exclude endobronchial obstruction before attributing non-expansion to pleural restriction 3
  • Place indwelling pleural catheter (IPC) for symptomatic relief, as 42.3% achieve spontaneous pleurodesis over median 126 days despite trapped lung 3

Special Considerations for Decortication

  • Decortication may be beneficial in pachypleuritis with bilateral involvement causing ventilatory failure, cor pulmonale, or CO₂ retention 3
  • Expect prolonged air leak (>7 days) in 32.6% of cases, with higher rates when extensive adhesions are present 5
  • Postoperative pneumoperitoneum after diaphragmatic manipulation is expected and does not require surgical re-exploration absent peritonitis 8

Critical Pitfalls to Avoid

  • Do not attempt pleurodesis without confirming complete lung expansion, as failure to expand indicates trapped lung or endobronchial obstruction requiring alternative management 3, 7
  • Do not rely solely on standard CT for detecting septations or adhesions, as transthoracic ultrasound provides superior sensitivity (81-88% vs 71%) 3
  • Do not dismiss tented diaphragmatic contours as always pathological, since normal anatomical variation of the pulmonary ligament can produce similar radiographic appearance 4
  • Do not underestimate functional impact of diffuse pleural thickening, as even minimal costophrenic angle blunting can cause significant FVC reduction comparable to extensive involvement 3
  • Do not proceed with VATS when preoperative imaging shows extensive adhesions without preparing for conversion to open thoracotomy, as inadequate visualization increases complication risk 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[The pulmonary ligament (pulmo-diaphragmatic ligament) (author's transl)].

RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1978

Guideline

Guideline Recommendations for Managing Adhesions in Women with Prior Cesarean Sections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Initial Management of Volume Loss in the Right Hemithorax

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Post-VATS Pneumoperitoneum After Diaphragmatic Repair

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.